Product
Mometasone furoate nasal spray
Aliases
Mometasone furoate nasal spray (MFNS), Nasonex Nasal Spray
5 clinical trials
5 indications
Indication
Allergic RhinitisIndication
Obstructive Sleep ApneaIndication
Sleep DisorderIndication
AsthmaClinical trial
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh StudyStatus: Recruiting, Estimated PCD: 2025-08-29
Clinical trial
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)Status: Completed, Estimated PCD: 2008-11-01
Clinical trial
A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study of Mometasone Furoate Nasal Spray (MFNS) In Subjects With Sleep-disordered Breathing Associated With Perennial Allergic Rhinitis (PAR) Using Home-Monitored Cardio-Respiratory Methodology.Status: Completed, Estimated PCD: 2008-01-01
Clinical trial
An Exploratory Study of Mometasone Furoate Nasal Spray in Patients With Moderate-severe Persistent Allergic Rhinitis and Intermittent Asthma: Effects on the Quality of Life Evaluated With the Rhinasthma QuestionnaireStatus: Completed, Estimated PCD: 2009-05-01
Clinical trial
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)Status: Completed, Estimated PCD: 2008-10-01